SEC Form 4 · accession 0001125345-18-000006
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Blasius Risser
Officer — Sr VP & Chief Business Officer
Period of report
Jan 17, 2018
Accepted (ET)
Jan 18, 2018 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 17, 2018 | M | 2,000 | $0.94 | A | 9,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) | $0.94 | Jan 17, 2018 | M | 2,000 | D | Sep 24, 2009 | Mar 23, 2019 | Common Stock | 2,000 | 29,497 | D |
Explanation of responses
- F1This amount includes 1,100 shares purchased through the Company's ESPP; 800 on 5/31/17 and 300 on 11/30/17.